openPR Logo
Press release

Plasma Fractionation Market Exclusive Report on the Latest Revenue and Future Scope

Plasma Fractionation Market Exclusive Report on the Latest

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Plasma Fractionation Market- (By Product (Immune-Globulins(Intravenous Immune-Globulins, Subcutaneous Immune-Globulins, Other Immune-Globulins), Coagulation Factor Concentrates (Factor VIII, Factor IX, Von Willebrand Factor, Prothrombin Complex Concentrate, Fibrinogen Concentrates, Factor XIII, Others), Albumin, Protease Inhibitors, Other Plasma Products), By Application (Neurology, Immunology, Hematology, Critical Care, Pulmonology, Hemato-Oncology, Rheumatology, Others), By End-User (Hospitals & Clinics, Clinical Research Laboratories, Academic Institutes)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Global Plasma Fractionation Market Size is valued at USD 4.2 Bn in 2023 and is predicted to reach USD 8.9 Bn by the year 2031 at a 10.1 % CAGR during the forecast period for 2024-2031.

Request For Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/2140

Fractionation is the process of isolating specific components from a mixture. In the medical field, plasma-the liquid portion of blood-is fractionated to obtain essential derivatives such as albumin and immunoglobulins. These plasma-derived products possess significant therapeutic properties and are widely used in the treatment of various blood plasma-related disorders.

The growing global elderly population, which is more susceptible to rare diseases requiring plasma derivatives, is a key factor driving the expansion of the plasma fractionation market. Additionally, the increasing utilization of immunoglobulins and alpha-1-antitrypsin across various medical applications is contributing to market growth. The rising number of plasma collection centers worldwide further supports this expansion. Moreover, proactive government initiatives aimed at increasing awareness regarding the benefits of plasma-derived therapies are fostering market development.

Prominent Players in the Plasma Fractionation Market:
• CSL (Australia)
• Takeda Pharmaceutical Company Limited (Japan)
• Grifols, S.A. (Spain)
• Octapharma AG (Switzerland)
• Kedrion S.P.A (Italy)
• LFB (France)
• ADMA Biologics (US)
• Sanquin (Netherlands)
• China Biologic Products Holdings Inc. (China)
• GC Pharma (Korea)
• Hualan Bioengineering Co., Ltd. (China)
• Japan Blood Products Organization (Japan)
• Emergent BioSolutions (US)
• Shanghai Raas Blood Products Co., Ltd. (China)
• Intas Pharmaceuticals Ltd. (India)
• Bharat Serum Vaccines Limited (India)
• SK Plasma (Korea)
• Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. (China)
• Kamada (Israel)
• Centurion Pharma (Istanbul)
• Prothya Biosolutions (Netherlands)
• PlasmaGen BioSciences Pvt. Ltd. (India)
• Virchow Biotech Private Limited (India)
• Fusion Healthcare (India)
• Hemarus Therapeutics Limited (India)
• Others

Market Dynamics:
Drivers-
The increasing prevalence of immunodeficiency disorders is a significant factor driving the expansion of the plasma fractionation market. The global demand for plasma-derived therapies has risen substantially, particularly for immunoglobulins, contributing to favorable market growth. In response to this surge in demand, leading industry players have intensified their research and development efforts to introduce innovative plasma-derived treatments.

Curious about this latest version of the report? Enquiry Before Buying:
https://www.insightaceanalytic.com/enquiry-before-buying/2140

Challenges:
The growing adoption of recombinant therapies as an alternative to plasma-derived medicines poses a challenge to market expansion. In recent years, numerous recombinant products have been developed as substitutes for plasma-derived treatments. These recombinant alternatives are widely used in prophylactic applications and are generally less immunogenic.

Regional Trends:
The Asia-Pacific region is anticipated to secure a significant market share in the plasma fractionation industry, with strong revenue growth and a high compound annual growth rate (CAGR) projected for the near future. Several factors contribute to this growth, including the presence of major companies specializing in the development and commercialization of technologically advanced plasma-derived therapies.

Additionally, North America is expected to witness rapid expansion in the coming years, driven by the presence of a large number of plasma fractionation centers, particularly in the United States, which plays a crucial role in supporting market growth.

Recent Developments:
• In March 2023, Takeda made an investment of 100 billion JPY in the establishment of a novel manufacturing facility in Japan, specifically dedicated to the production of plasma-derived medicines. The investment made by Takeda exemplified the company's dedication to prioritising patients and fulfilling its obligations in relation to its patient-centric, people-oriented, and environmentally conscious objectives. This approach was supported by the utilisation of data and digital technologies.
• In Dec 2022, CSL has recently inaugurated its Plasma Fractionation Facility in Victoria, Australia, which represents a significant milestone in the country's plasma manufacturing sector. With a staggering investment of $900 Bn, this state-of-the-art facility stands as the largest of its type in the Southern Hemisphere. The aforementioned statement pertains to a capital investment programme of over $2 billion that CSL is presently implementing in Australia.

Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customisation/2140

Segmentation of Plasma Fractionation Market-
By Product-
• Immune-Globulins
o Intravenous Immune-Globulins
o Subcutaneous Immune-Globulins
o Other Immune-Globulins
• Coagulation Factor Concentrates
o Factor VIII
o Factor IX
o Von Willebrand Factor
o Prothrombin Complex Concentrate
o Fibrinogen Concentrates
o Factor XIII
o Others
• Albumin
• Protease Inhibitors
• Other Plasma Products
By Application-
• Neurology
• Immunology
• Hematology
• Critical Care
• Pulmonology
• Hemato-Oncology
• Rheumatology
• Others
By End-User-
• Hospitals & Clinics
• Clinical Research Laboratories
• Academic Institutes
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Get More Information: @
https://www.insightaceanalytic.com/report/plasma-fractionation-market/2140

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.

Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Plasma Fractionation Market Exclusive Report on the Latest Revenue and Future Scope here

News-ID: 4152032 • Views:

More Releases from Insightace Analytic Pvt Ltd.

Pet Food E-commerce Market Growth Mapping and Forecast Study 2026 to 2035
Pet Food E-commerce Market Growth Mapping and Forecast Study 2026 to 2035
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Pet Food E-commerce Market Size, Share & Trends Analysis Report by Pet Type (Dogs (Dry Food, Wet Food, Snacks/Treats), Cats (Dry Food, Wet Food, Snacks/Treats), Others (Dry Food, Wet Food, Snacks/Treats), by Price Range (Economy, Mid-Range, Premium) Market Outlook And Industry Analysis 2035" Pet Food E-commerce Market Size is valued at USD 20.93 Bn in 2025
Motorcycle Connected Helmet Market Global Demand Analysis and Forecast 2026 to 2035
Motorcycle Connected Helmet Market Global Demand Analysis and Forecast 2026 to 2 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Motorcycle Connected Helmet Market Size, Share & Trends Analysis Report by Type (Full-Face Helmets, Half-Face Helmets, Modular Helmets), by Connectivity Features (Bluetooth Connectivity, GPS Navigation, Music Streaming, SOS Emergency Alert), by Camera Features (Front-Facing Cameras, Rear-Facing Cameras, 360-Degree Cameras), by Sensor Technology (Accelerometers, Gyroscopes, Magnetometers, Barometers) Market Outlook And Industry Analysis 2035" Motorcycle Connected Helmet
OTOF Gene Therapy for Hearing Loss Market Competitive Landscape and Outlook 2026 to 2035
OTOF Gene Therapy for Hearing Loss Market Competitive Landscape and Outlook 2026 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global OTOF Gene Therapy for Hearing Loss Market Size, Share & Trends Analysis Report by Type (Dual AAV Vector-Based, Single AAV Vector-Based, LNP-Based mRNA), by Patient Population (Pediatric (Congenital), Adult (Early Onset), Late-Stage Hearing Loss), by Distribution Channel (Hospital Specialty Clinics, ENT Centers, Rare Disease Treatment Centers),- Market Outlook And Industry Analysis 2035" OTOF Gene Therapy for
AI-Enabled Medical Device Software (AI-DSF) Market Expansion Potential and Revenue Projection 2026 to 2035
AI-Enabled Medical Device Software (AI-DSF) Market Expansion Potential and Reven …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global AI-Enabled Medical Device Software (AI-DSF) Market Size, Share & Trends Analysis Report by Device Type (Diagnostic Imaging AI, Remote Patient Monitoring, AI-Assisted Surgical Robotics, Clinical Decision Support), by Application (Radiology, Cardiology, Oncology, Neurology), by End User (Hospitals, Diagnostic Labs, Ambulatory Surgical Centers),- Market Outlook And Industry Analysis 2035" AI Enabled Medical Device Software (AI-DSF) Market Size

All 5 Releases


More Releases for Plasma

Plasma-Derived Therapeutics Market (2025) | Plasma-Derived Therapies, Plasma Fra …
Market Growth & Size 2025-2033 plasma-derived therapeutics market was valued at US$ 20.16 Billion in 2023. The market size reached US$ 21.26 Billion in 2024 and is expected to reach US$ 35.10 Billion by 2033, growing at a CAGR of 6.4% during the forecast period 2025-2033. Connect with the right partners and unlock new growth opportunities today:- https://www.datamintelligence.com/partner-identification-enquiry/plasma-derived-therapeutics-market?kb United States: Recent Industry Developments ✅ March 2026: CSL Behring expanded plasma fractionation capacity in the
Blood Plasma Freezers Market Safeguarding Plasma Derivatives: Blood Plasma Freez …
Global Blood Plasma Freezers Market Worth $772.0 Mn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Blood Plasma Freezers Market- (By Type (Manual Defrost, Automatic Defrost), By Application (Hospital, Laboratory), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by InsightAce Analytic, the Global Blood Plasma Freezers Market
Contract Plasma Coating Service Market Analysis, Size, Share, Trends, Growth And …
The Global Contract Plasma Coating Service Market report is added by WMR to its database to offer a complete assessment of the factors influencing an overall market growth trend. The research covers significant data and proves to be a handy resource document for industry experts. The research is a perfect balance bridging both qualitative and quantitative information of this market. Quantitative statistics with qualitative reasoning related to market size, share,
Cold Plasma Market Analysis By Top Keyplayers - Plasma Air, Atmospheric plasma t …
The "Cold Plasma Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031.  The market was valued at USD xx.x billion In 2023. Growing Demand and Growth Potential in the Global Cold Plasma Market, 2024-2031 Verified Market Research's most recent report, "Cold Plasma Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides an in-depth examination
Contract Plasma Coating Service Market Players Leveraging on Growth Opportunitie …
The Most recent study offered by "Stratagem Market Insights" focuses on Contract Plasma Coating Service Market size, share, growth rate, and market trends, as well as the parameters and factors influencing it in both the long term and short term. The report investigates the market trends in order to assess its current and future potential. Our Market analysis also provides market participants and new entrants with a comprehensive view of
Cold Plasma Market Size, Share - Global Industry Forecast 2032 | Relyon Plasma G …
The market research report offers an in-depth analysis of the Cold Plasma market, helping players to prepare for the increasing hurdles ahead and ensure continued business expansion. With impeccable analysis, exhaustive research, and accurate forecasting, we provide a clear and authoritative study of the global Cold Plasma market, backed by data and figures that have undergone a rigorous verification process. This research is an exhaustive, comprehensive and carefully curated source